{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:44:38Z","timestamp":1787316278838,"version":"build-2736575974"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["GM059658-08S1"],"award-info":[{"award-number":["GM059658-08S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.abb.2019.01.032","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:43:09Z","timestamp":1548808989000},"page":"51-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pre-structured hydrophobic peptide \u03b2-strands: A universal amyloid trap?"],"prefix":"10.1016","volume":"664","author":[{"given":"Kalkena","family":"Sivanesam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2019.01.032_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0959-440X(99)00049-4","article-title":"Amyloid fibrillogenesis: themes and variations","volume":"10","author":"Rochet","year":"2000","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.abb.2019.01.032_bib2","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1021\/bi0160462","article-title":"Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis","volume":"41","author":"Padrick","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib3","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1073\/pnas.0703306104","article-title":"Fiber-dependent amyloid formation as catalysis of an existing reaction pathway","volume":"104","author":"Ruschak","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.abb.2019.01.032_bib4","doi-asserted-by":"crossref","first-page":"16742","DOI":"10.1073\/pnas.262663499","article-title":"A structural model for Alzheimer's \u03b2-amyloid fibrils based on experimental constraints from solid state NMR","volume":"99","author":"Petkova","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.abb.2019.01.032_bib5","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1073\/pnas.0712179105","article-title":"The fold of alpha-synuclein fibrils","volume":"105","author":"Vilar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.abb.2019.01.032_bib6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","article-title":"Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein","volume":"122","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.abb.2019.01.032_bib7","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.abb.2019.01.032_bib8","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/j.1460-2075.1985.tb04000.x","article-title":"Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels","volume":"4","author":"Masters","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.abb.2019.01.032_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer's disease and the \u03b2-amyloid peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.abb.2019.01.032_bib10","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.abb.2019.01.032_bib11","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.abb.2019.01.032_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/B978-0-12-385883-2.00010-2","article-title":"Huntington disease and the huntingtin protein","volume":"107","author":"Zheng","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.abb.2019.01.032_bib13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.abb.2019.01.032_bib14","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.bpj.2012.04.050","article-title":"Fibrillar \u03b1-synuclein and huntingtin exon 1 assemblies are toxic to the cells","volume":"102","author":"Pieri","year":"2012","journal-title":"Biophys. J."},{"key":"10.1016\/j.abb.2019.01.032_bib15","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/emboj.2009.257","article-title":"Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models","volume":"28","author":"Karpinar","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.abb.2019.01.032_bib16","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that \u03b1-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.abb.2019.01.032_bib17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/NEN.0b013e318217a118","article-title":"Brain oligomeric \u03b2-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein\/tau transgenic mice","volume":"70","author":"DaRocha-Souto","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.abb.2019.01.032_bib18","series-title":"Neurodegenerative Diseases","first-page":"109","article-title":"The non-amyloid-\u03b2 component of Alzheimer's disease plaque amyloid: comparative analysis suggests a normal function as a synaptic plasticizer","author":"George","year":"1996"},{"key":"10.1016\/j.abb.2019.01.032_bib19","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.abb.2019.01.032_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.abb.2019.01.032_bib21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.abb.2019.01.032_bib22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of alpha-synuclein in its free and lipid-associated states","volume":"307","author":"Eliezer","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.abb.2019.01.032_bib23","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.1021\/ja804517m","article-title":"Membrane-bound alpha-synuclein forms an extended helix: long-distance pulsed ESR measurements using vesicles, bicelles, and rodlike micelles","volume":"130","author":"Georgieva","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.abb.2019.01.032_bib24","doi-asserted-by":"crossref","first-page":"19666","DOI":"10.1073\/pnas.0807826105","article-title":"Structure of membrane-bound \u03b1-synuclein from site-directed spin labeling and computational refinement","volume":"105","author":"Jao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.abb.2019.01.032_bib25","volume":"vol. 7","author":"Guerrero-Ferreira","year":"2018"},{"key":"10.1016\/j.abb.2019.01.032_bib26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","article-title":"Amyloid fibril structure of \u03b1-synuclein determined by cryo-electron microscopy","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.abb.2019.01.032_bib27","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","article-title":"Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.abb.2019.01.032_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature15368","article-title":"Structure of the toxic core of \u03b1-synuclein from invisible crystals","volume":"525","author":"Rodriguez","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.abb.2019.01.032_bib29","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.01.032_bib30","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1002\/anie.201309001","article-title":"Sequestration of a \u03b2-hairpin for control of \u03b1-synuclein aggregation","volume":"53","author":"Mirecka","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.abb.2019.01.032_bib31","doi-asserted-by":"crossref","first-page":"11577","DOI":"10.1039\/C5RA00325C","article-title":"Binding interactions of agents that alter \u03b1-synuclein aggregation","volume":"5","author":"Sivanesam","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.abb.2019.01.032_bib32","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1021\/jacs.5b13261","article-title":"X-ray crystallographic structure of oligomers formed by a toxic \u03b2-hairpin derived from \u03b1-synuclein: trimers and higher-order oligomers","volume":"138","author":"Salveson","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.abb.2019.01.032_bib33","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","article-title":"Mutant and wild type human \u03b1-synucleins assemble into elongated filaments with distinct morphologies in vitro","volume":"274","author":"Giasson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.01.032_bib34","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","article-title":"Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid","volume":"39","author":"Conway","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.abb.2019.01.032_bib36","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1021\/bi010616g","article-title":"Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human \u03b1-synuclein","volume":"40","author":"Li","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","article-title":"Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein","volume":"576","author":"Choi","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.abb.2019.01.032_bib38","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1074\/jbc.M411638200","article-title":"The E46K mutation in alpha-synuclein increases amyloid fibril formation","volume":"280","author":"Greenbaum","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.01.032_bib39","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1021\/bi5010365","article-title":"The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates \u03b1-synuclein aggregation and membrane binding","volume":"53","author":"Ghosh","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","article-title":"\u03b1-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?","volume":"125","author":"Kiely","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.abb.2019.01.032_bib41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease","volume":"28","author":"Appel-Cresswell","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.abb.2019.01.032_bib42","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/ja044834j","article-title":"Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations","volume":"127","author":"Dedmon","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.abb.2019.01.032_bib43","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1073\/pnas.0407146102","article-title":"Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein","volume":"102","author":"Bertoncini","year":"2005","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.abb.2019.01.032_bib44","doi-asserted-by":"crossref","first-page":"17968","DOI":"10.1021\/ja055538p","article-title":"Defining long-range order and local disorder in native alpha-synuclein using residual dipolar couplings","volume":"127","author":"Bernad\u00f3","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.abb.2019.01.032_bib45","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1021\/bi048453u","article-title":"Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro","volume":"43","author":"Hoyer","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib46","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1021\/bi027363r","article-title":"Role of \u03b1-synuclein carboxy-terminus on fibril formation in vitro\u2020","volume":"42","author":"Murray","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib47","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.febslet.2011.03.046","article-title":"Inhibition and disaggregation of \u03b1-synuclein oligomers by natural polyphenolic compounds","volume":"585","author":"Caruana","year":"2011","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.abb.2019.01.032_bib48","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.bbamem.2012.05.019","article-title":"Polyphenolic compounds are novel protective agents against lipid membrane damage by \u03b1-synuclein aggregates in vitro","volume":"1818","author":"Caruana","year":"2012","journal-title":"BBA- Biomembranes"},{"key":"10.1016\/j.abb.2019.01.032_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00197","article-title":"Structure activity relationship of phenolic acid inhibitors of \u03b1-synuclein fibril formation and toxicity","volume":"6","author":"Ardah","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.abb.2019.01.032_bib50","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/bph.13492","article-title":"Antioxidant effects of resveratrol in the cardiovascular system","volume":"174","author":"Xia","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.abb.2019.01.032_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2008.10.005","article-title":"Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats","volume":"600","author":"Jin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.abb.2019.01.032_bib52","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.pnpbp.2008.03.024","article-title":"Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice","volume":"32","author":"Blanchet","year":"2008","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.abb.2019.01.032_bib53","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1471-4159.2009.06228.x","article-title":"The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by \u03b1-synuclein or amyloid-\u03b2 (1-42) peptide","volume":"110","author":"Albani","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.abb.2019.01.032_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1756-6606-2-29","article-title":"The emerging role of autophagy in Parkinson's disease","volume":"2","author":"Cheung","year":"2009","journal-title":"Mol. Brain"},{"key":"10.1016\/j.abb.2019.01.032_bib55","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.bbapap.2014.04.013","article-title":"Gallic acid interacts with \u03b1-synuclein to prevent the structural collapse necessary for its aggregation","volume":"1844","author":"Liu","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.abb.2019.01.032_bib56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.febslet.2014.11.026","article-title":"The green tea polyphenol (\u2212)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios","volume":"589","author":"Wobst","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.abb.2019.01.032_bib57","article-title":"The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer's disease: an overview of pre-clinical studies and translational perspectives in clinical practice","volume":"12","author":"Cascella","year":"2017","journal-title":"Infect. Agents Canc."},{"key":"10.1016\/j.abb.2019.01.032_bib58","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.abb.2019.01.032_bib59","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.abb.2019.01.032_bib60","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M114.554667","article-title":"How epigallocatechin gallate can inhibit \u03b1-synuclein oligomer toxicity in vitro","author":"Lorenzen","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.01.032_bib61","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1074\/jbc.M403129200","article-title":"The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils","volume":"279","author":"Zhu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.01.032_bib62","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M408714200","article-title":"Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins","volume":"280","author":"Taniguchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.01.032_bib63","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.1021\/bi900506b","article-title":"Molecular mechanisms underlying the flavonoid-induced inhibition of \u03b1-synuclein fibrillation","volume":"48","author":"Meng","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.nbd.2017.07.007","article-title":"Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form","volume":"106","author":"Collier","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.abb.2019.01.032_bib65","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4161\/hv.6.11.13217","article-title":"AFFITOME\u00ae technology in neurodegenerative diseases: the doubling advantage","volume":"6","author":"Schneeberger","year":"2010","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.abb.2019.01.032_bib66","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-014-1256-4","article-title":"Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials","volume":"127","author":"Mandler","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.abb.2019.01.032_bib67","series-title":"Foxfeed Blog. Parkinson's Vaccine Safe In Phase I Trial","author":"Kuhl","year":"2014"},{"key":"10.1016\/j.abb.2019.01.032_bib68","series-title":") Foxfeed Blog. Vaccine For Parkinson's Reports Positive Results From Boost Study","author":"Kuhl","year":"2016"},{"key":"10.1016\/j.abb.2019.01.032_bib69","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1096\/fj.03-1346fje","article-title":"A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders","volume":"18","author":"El-Agnaf","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.abb.2019.01.032_bib70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1399-3011.2002.11002.x","article-title":"Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Abeta1-40 fibrillogenesis","volume":"60","author":"Gordon","year":"2002","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.abb.2019.01.032_bib71","doi-asserted-by":"crossref","first-page":"13905","DOI":"10.1074\/jbc.M211976200","article-title":"Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease","volume":"278","author":"Adessi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.01.032_bib72","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.1021\/bi060837s","article-title":"N-Methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure","volume":"45","author":"Kokkoni","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib73","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1046\/j.1432-1327.2000.01219.x","article-title":"Toxicity of non-A\u03b2 component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of \u03b2-sheet structure and fibrils","volume":"267","author":"Bodles","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.abb.2019.01.032_bib74","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1471-4159.2001.00408.x","article-title":"Identification of the region of non-A\u03b2 component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity","volume":"78","author":"Bodles","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.abb.2019.01.032_bib75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2003.12.077","article-title":"Inhibition of fibril formation and toxicity of a fragment of alpha-synuclein by an N-methylated peptide analogue","volume":"359","author":"Bodles","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.abb.2019.01.032_bib76","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.5.5.527","article-title":"The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands of langerhahns","volume":"5","author":"Opie","year":"1901","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.abb.2019.01.032_bib77","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","article-title":"A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas","volume":"140","author":"Westermark","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl 3","key":"10.1016\/j.abb.2019.01.032_bib78","first-page":"101S","article-title":"The physiology of amylin and insulin: maintaining the balance between glucose secretion and glucose uptake","volume":"32","author":"Martin","year":"2006","journal-title":"Diabetes Educat."},{"key":"10.1016\/j.abb.2019.01.032_bib79","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/edrv-15-2-163","article-title":"Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease","volume":"15","author":"Cooper","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.abb.2019.01.032_bib80","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0029-1211958","article-title":"The role of amylin in the physiology of glycemic control","volume":"106","author":"Scherbaum","year":"1998","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.abb.2019.01.032_bib81","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/014572179902500310","article-title":"Clinical implications of amylin and amylin deficiency","volume":"25","author":"Kruger","year":"1999","journal-title":"Diabetes Educat."},{"key":"10.1016\/j.abb.2019.01.032_bib82","doi-asserted-by":"crossref","first-page":"E443","DOI":"10.1152\/ajpendo.2001.280.3.E443","article-title":"Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas","volume":"280","author":"Silvestre","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.abb.2019.01.032_bib83","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-0115(02)00252-5","article-title":"Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets","volume":"111","author":"Akesson","year":"2003","journal-title":"Regul. Pept."},{"key":"10.1016\/j.abb.2019.01.032_bib84","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1074\/jbc.271.4.1988","article-title":"pore formation by the cytotoxic islet amyloid peptide amylin","volume":"271","author":"Mirzabekov","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.01.032_bib85","doi-asserted-by":"crossref","first-page":"46363","DOI":"10.1074\/jbc.C400260200","article-title":"Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases","volume":"279","author":"Kayed","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.01.032_bib86","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0006-8993(95)00148-J","article-title":"Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium","volume":"676","author":"Mattson","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.abb.2019.01.032_bib87","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1073\/pnas.92.6.1989","article-title":"Amyloid peptides are toxic via a common oxidative mechanism","volume":"92","author":"Schubert","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 3","key":"10.1016\/j.abb.2019.01.032_bib88","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1042\/bj3220859","article-title":"Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction","volume":"322","author":"Tomiyama","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.abb.2019.01.032_bib89","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","article-title":"Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus","volume":"368","author":"Lorenzo","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.abb.2019.01.032_bib90","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-5793(99)00894-7","article-title":"Induction of apoptosis by human amylin in RINm5F islet beta-cells is associated with enhanced expression of p53 and p21WAF1\/CIP1","volume":"455","author":"Zhang","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.abb.2019.01.032_bib91","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-2836(02)01044-6","article-title":"Increased expression and activation of c-Jun contributes to human amylin-induced apoptosis in pancreatic islet beta-cells","volume":"324","author":"Zhang","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.abb.2019.01.032_bib92","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2337\/db07-0849","article-title":"Fas-associated death receptor signaling evoked by human amylin in islet beta-cells","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.abb.2019.01.032_bib93","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1110\/ps.062486907","article-title":"Direct detection of transient \u03b1-helical states in islet amyloid polypeptide","volume":"16","author":"Williamson","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/j.abb.2019.01.032_bib94","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1006\/jmbi.1999.2646","article-title":"Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro","volume":"287","author":"Kayed","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.abb.2019.01.032_bib95","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/jsbi.2000.4268","article-title":"Amyloid fibril formation from full-length and fragments of amylin","volume":"130","author":"Goldsbury","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.abb.2019.01.032_bib96","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1529\/biophysj.107.110635","article-title":"Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy","volume":"93","author":"Lopes","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.abb.2019.01.032_bib97","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.1021\/bi800828u","article-title":"Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state","volume":"47","author":"Yonemoto","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib98","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1021\/jp810261x","article-title":"Two-dimensional infrared spectroscopy provides evidence of an intermediate in the membrane-catalyzed assembly of diabetic amyloid","volume":"113","author":"Ling","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.abb.2019.01.032_bib99","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.1021\/bi200760h","article-title":"Designed hairpin peptides interfere with amyloidogenesis pathways: fibril formation and cytotoxicity inhibition, interception of the preamyloid state","volume":"50","author":"Huggins","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib100","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/1873-3468.12261","article-title":"Peptide Inhibitors of the amyloidogenesis of IAPP: verification of the hairpin-binding geometry hypothesis","volume":"590","author":"Sivanesam","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.abb.2019.01.032_bib101","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/pro.145","article-title":"Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process","volume":"18","author":"Wiltzius","year":"2009","journal-title":"Protein Sci."},{"key":"10.1016\/j.abb.2019.01.032_bib102","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1021\/bi3014278","article-title":"Role of aromatic interactions in amyloid formation by islet amyloid polypeptide","volume":"52","author":"Tu","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib103","doi-asserted-by":"crossref","first-page":"9516","DOI":"10.1021\/ja8097417","article-title":"Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study","volume":"131","author":"Evers","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.abb.2019.01.032_bib104","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1021\/acs.biochem.6b01016","article-title":"Islet amyloid polypeptide membrane interactions: effects of membrane composition","volume":"56","author":"Zhang","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-5793(00)01287-4","article-title":"Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils","volume":"470","author":"Higham","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.abb.2019.01.032_bib106","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1021\/bi901751b","article-title":"The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors","volume":"49","author":"Cao","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib107","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1074\/jbc.270.7.3063","article-title":"The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation","volume":"270","author":"Soto","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.01.032_bib108","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1073\/pnas.85.20.7763","article-title":"Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle","volume":"85","author":"Cooper","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Pt 1","key":"10.1016\/j.abb.2019.01.032_bib109","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/bj2770139","article-title":"Cross-reactivity of amylin with calcitonin-gene-related peptide binding sites in rat liver and skeletal muscle membranes","volume":"277","author":"Chantry","year":"1991","journal-title":"Biochem. J."},{"issue":"Suppl 2","key":"10.1016\/j.abb.2019.01.032_bib110","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/(SICI)1096-9136(199706)14:2+<S35::AID-DIA402>3.0.CO;2-8","article-title":"Amylin and glycaemic regulation: a possible role for the human amylin analogue pramlintide","volume":"14","author":"Kolterman","year":"1997","journal-title":"Diabet. Med."},{"key":"10.1016\/j.abb.2019.01.032_bib111","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2337\/diacare.18.8.1179","article-title":"Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue","volume":"18","author":"Kolterman","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.abb.2019.01.032_bib112","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/(SICI)1096-9136(199707)14:7<547::AID-DIA390>3.0.CO;2-U","article-title":"Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes","volume":"14","author":"Thompson","year":"1997","journal-title":"Diabet. Med."},{"key":"10.1016\/j.abb.2019.01.032_bib113","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1038\/ncomms3825","article-title":"A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice","volume":"4","author":"R\u00f6ssger","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.abb.2019.01.032_bib114","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/VHRM.S1978","article-title":"Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk","volume":"4","author":"Hoogwerf","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.abb.2019.01.032_bib115","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/oby.2009.184","article-title":"Enhanced weight loss with pramlintide\/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy","volume":"17","author":"Ravussin","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.abb.2019.01.032_bib116","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/cbic.200800762","article-title":"Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol","volume":"10","author":"Mishra","year":"2009","journal-title":"Chembiochem"},{"key":"10.1016\/j.abb.2019.01.032_bib117","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.bpj.2011.02.010","article-title":"Resveratrol inhibits the formation of multiple-layered \u03b2-sheet oligomers of the human islet amyloid polypeptide segment 22-27","volume":"100","author":"Jiang","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.abb.2019.01.032_bib118","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/bi501016r","article-title":"Mutational analysis of the ability of resveratrol to inhibit amyloid formation by islet amyloid polypeptide: critical evaluation of the importance of aromatic-inhibitor and histidine-inhibitor interactions","volume":"54","author":"Tu","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib119","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1021\/acs.biochem.6b00578","article-title":"Amylin amyloid inhibition by flavonoid baicalein: key roles of its vicinal dihydroxyl groups of the catechol moiety","volume":"55","author":"Velander","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib120","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1096\/fj.201700236R","article-title":"Amyloid-induced \u03b2-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment","volume":"31","author":"Montane","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.abb.2019.01.032_bib121","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1021\/ja072157y","article-title":"A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor","volume":"129","author":"Abedini","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.abb.2019.01.032_bib122","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1006\/jmbi.1999.3422","article-title":"Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties 1","volume":"295","author":"Tenidis","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.abb.2019.01.032_bib123","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0022-2836(02)00887-2","article-title":"Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide","volume":"322","author":"Mazor","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.abb.2019.01.032_bib124","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/jmbi.2001.5244","article-title":"Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity 1","volume":"315","author":"Kapurniotu","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.abb.2019.01.032_bib125","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.chembiol.2005.05.010","article-title":"Inhibition of hIAPP amyloid-fibril formation and apoptotic cell death by a designed hIAPP amyloid- core-containing hexapeptide","volume":"12","author":"Tatarek-Nossol","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.abb.2019.01.032_bib126","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0507471103","article-title":"Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis","volume":"103","author":"Yan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.abb.2019.01.032_bib127","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1021\/bi701427q","article-title":"Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR","volume":"46","author":"Luca","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib128","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1110\/ps.036509.108","article-title":"Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin)","volume":"17","author":"Wiltzius","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.abb.2019.01.032_bib129","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1073\/pnas.0805957106","article-title":"Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution","volume":"106","author":"Shim","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.abb.2019.01.032_bib130","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1021\/acs.biochem.7b00739","article-title":"Inhibition of human amylin amyloidogenesis by human amylin-fragment peptides: exploring the effects of serine residues and oligomerization upon inhibitory potency","volume":"56","author":"Sivanesam","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib131","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1021\/acs.biochem.5b00061","article-title":"Self-assembly of a nine-residue amyloid-forming peptide fragment of SARS corona virus E-protein: mechanism of self aggregation and amyloid-inhibition of hIAPP","volume":"54","author":"Ghosh","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib132","doi-asserted-by":"crossref","first-page":"14456","DOI":"10.1021\/ja065557e","article-title":"Inhibition of \u03b2-amyloid fibrillization by directed evolution of a \u03b2-sheet presenting miniature protein","volume":"128","author":"Smith","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.abb.2019.01.032_bib133","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.abb.2019.01.032_bib134","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bbadis.2008.07.004","article-title":"Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties","volume":"1782","author":"Ulrih","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.abb.2019.01.032_bib135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.abb.2019.01.032_bib136","doi-asserted-by":"crossref","first-page":"16895","DOI":"10.1074\/jbc.M800747200","article-title":"Phosphorylation at ser-129 but not the phosphomimics S129E\/D inhibits the fibrillation of \u03b1-synuclein","volume":"283","author":"Paleologou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.01.032_bib137","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1385\/NMM:4:1-2:49","article-title":"Interactions of amyloidogenic proteins","volume":"4","author":"Giasson","year":"2003","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.abb.2019.01.032_bib138","doi-asserted-by":"crossref","first-page":"16485","DOI":"10.1074\/jbc.R116.714576","article-title":"Cross-interactions between the alzheimer disease amyloid-\u03b2 peptide and other amyloid proteins: a further aspect of the amyloid cascade hypothesis","volume":"291","author":"Luo","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.01.032_bib139","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/anie.201105877","article-title":"Cross-amyloid interaction of A\u03b2 and IAPP at lipid membranes","volume":"51","author":"Seeliger","year":"2012","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.abb.2019.01.032_bib140","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/mp.2016.230","article-title":"Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding","volume":"22","author":"Moreno-Gonzalez","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.abb.2019.01.032_bib141","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic interactions between A\u03b2, tau, and \u03b1-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.abb.2019.01.032_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020289","article-title":"Interaction between Amyloid Beta Peptide and an Aggregation Blocker Peptide Mimicking Islet Amyloid Polypeptide","volume":"6","author":"Rezaei-Ghaleh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.abb.2019.01.032_bib143","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1471-4159.2012.07847.x","article-title":"Cross-seeding effects of amyloid \u03b2-protein and \u03b1-synuclein","volume":"122","author":"Ono","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.abb.2019.01.032_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106883","article-title":"Cross dimerization of amyloid-\u03b2 and \u03b1Synuclein proteins in aqueous environment: a molecular dynamics simulations study","volume":"9","author":"Jose","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.abb.2019.01.032_bib145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CIA.S74042","article-title":"Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment","volume":"10","author":"Li","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.abb.2019.01.032_bib146","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4239\/wjd.v6.i5.744","article-title":"Emerging links between type 2 diabetes and Alzheimer's disease","volume":"6","author":"Sridhar","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.abb.2019.01.032_bib147","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.abb.2019.01.032_bib148","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/aps.2011.14","article-title":"Small molecule inhibitors of amyloid \u03b2 peptide aggregation as a potential therapeutic strategy for Alzheimer's disease","volume":"32","author":"Nie","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.abb.2019.01.032_bib149","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/bi100939a","article-title":"The flavanol (\u2212)-Epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity","volume":"49","author":"Meng","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.01.032_bib150","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/anie.200604056","article-title":"IAPP mimic blocks Abeta cytotoxic self-assembly: cross-suppression of amyloid toxicity of Abeta and IAPP suggests a molecular link between Alzheimer's disease and type II diabetes","volume":"46","author":"Yan","year":"2007","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.abb.2019.01.032_bib151","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1002\/anie.200904902","article-title":"Identification of hot regions of the Abeta-IAPP interaction interface as high-affinity binding sites in both cross- and self-association","volume":"49","author":"Andreetto","year":"2010","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.abb.2019.01.032_bib152","doi-asserted-by":"crossref","first-page":"13095","DOI":"10.1002\/anie.201504973","article-title":"A hot-segment-based approach for the design of cross-amyloid interaction Surface mimics as inhibitors of amyloid self-assembly","volume":"54","author":"Andreetto","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.abb.2019.01.032_bib153","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/ml300478w","article-title":"Designed trpzip-3 \u03b2-hairpin inhibits amyloid formation in two different amyloid systems","volume":"4","author":"Hopping","year":"2013","journal-title":"ACS Med. Chem. Lett."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986118307379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986118307379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:08:58Z","timestamp":1757743738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986118307379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":153,"alternative-id":["S0003986118307379"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2019.01.032","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-structured hydrophobic peptide \u03b2-strands: A universal amyloid trap?","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2019.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}